Quo vadis (where are you going) pharmacovigilance? (2023)

First Author: Kulkarni S
Attributed to:  AstraZeneca Secondment for Clinical Pharmacology Training funded by FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15584

PubMed Identifier: 36398325

Publication URI: http://europepmc.org/abstract/MED/36398325

Type: Journal Article/Review

Volume: 89

Parent Publication: British journal of clinical pharmacology

Issue: 2

ISSN: 0306-5251